MANGOCEUTICALS, INC. (MGRX): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 17:25 ET
- Event date
- 2026-11-06
- Accession no.
- 0001493152-26-051858
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
Mangoceuticals establishes Series D preferred stock and amends Series B and Series C rights
Mangoceuticals established 1,000,000 shares of 8% Series D Convertible Cumulative Preferred Stock and amended its Series B and Series C designations to accommodate it. Series D ranks senior to common stock, Series B and Series C for dividends and liquidation distributions. The charter filings did not themselves issue any Series D shares.
- The Series B and Series C amendments and Series D designation took effect November 9, 2026.
- Series D has a $10.00 stated value and an initial annual dividend rate of 8%.
- Series D has a liquidation preference of $15.00 per share plus accrued and unpaid dividends.
- The charter filings did not themselves result in the issuance of any Series D Preferred Stock.
governance
Items reported
- Item 3.03: Material Modifications to Rights of Security Holders
The rights of holders of a class of the company's securities were materially modified, for example by a charter amendment, a rights plan or a reverse stock split. - Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
The company amended its articles of incorporation or bylaws without a shareholder vote that was previously disclosed, or changed its fiscal year. - Item 5.07: Submission of Matters to a Vote of Security Holders
The company reports the results of a shareholder meeting: each matter voted on and the votes cast for, against, abstaining and broker non-votes. - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | form8-k.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.